ETV Bharat / bharat

SII CEO Adar Poonawalla to get 'Y' category security

Serum Institute of India's CEO Adar Poonawalla will get 'Y' category security across India by the CRPF following threats from various groups regarding the COVID-19 vaccine supplies.

SII CEO Adar Poonawalla to get 'Y' category security
SII CEO Adar Poonawalla to get 'Y' category security
author img

By

Published : Apr 28, 2021, 8:33 PM IST

Updated : Apr 28, 2021, 9:36 PM IST

New Delhi: Serum Institute of India's CEO Adar Poonawalla will get 'Y' category security across India by the CRPF, the Union government officials said on Wednesday.

The Union government's decision came after the Director, Government and Regulatory Affairs at Pune-based Serum Institute of India (SII), Prakash Kumar Singh had written to Union Home Minister Amit Shah on April 16 requesting security for Poonawalla.

Read:| Serum Institute prices Covishield at Rs 400/dose for govts; Rs 600/dose for pvt hospitals

Covishield, one of the two COVID-19 vaccines used in India's COVID-19 vaccination programme, is being manufactured by SII.

In this letter, Singh had stated that Poonawalla has been getting threats from various groups regarding the COVID-19 vaccine supplies.

Read:| Govt asks SII, Bharat Biotech to lower price of Covid vax: Sources

In this letter, Singh also said, "we are working shoulder to shoulder to fight against the COVID-19 pandemic with the Government of India under the dynamic leadership of Prime Minister Narendra Modi Ji."

PTI

Read:| SII defends pricing, says Covishield 'most affordable vaccine in market'

New Delhi: Serum Institute of India's CEO Adar Poonawalla will get 'Y' category security across India by the CRPF, the Union government officials said on Wednesday.

The Union government's decision came after the Director, Government and Regulatory Affairs at Pune-based Serum Institute of India (SII), Prakash Kumar Singh had written to Union Home Minister Amit Shah on April 16 requesting security for Poonawalla.

Read:| Serum Institute prices Covishield at Rs 400/dose for govts; Rs 600/dose for pvt hospitals

Covishield, one of the two COVID-19 vaccines used in India's COVID-19 vaccination programme, is being manufactured by SII.

In this letter, Singh had stated that Poonawalla has been getting threats from various groups regarding the COVID-19 vaccine supplies.

Read:| Govt asks SII, Bharat Biotech to lower price of Covid vax: Sources

In this letter, Singh also said, "we are working shoulder to shoulder to fight against the COVID-19 pandemic with the Government of India under the dynamic leadership of Prime Minister Narendra Modi Ji."

PTI

Read:| SII defends pricing, says Covishield 'most affordable vaccine in market'

Last Updated : Apr 28, 2021, 9:36 PM IST
ETV Bharat Logo

Copyright © 2025 Ushodaya Enterprises Pvt. Ltd., All Rights Reserved.